| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |